DOI:
10.1055/s-00000167
International Journal of Angiology
LinksClose Window
References
Fitchett D, Zinman B, Wanner C. et al; EMPA-REG OUTCOME® trial investigators.
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial.
Eur Heart J 2016;
37 (19) 1526-1534
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.